Literature DB >> 17030669

POMGnT1 mutations in congenital muscular dystrophy: genotype-phenotype correlation and expanded clinical spectrum.

Roberta Biancheri1, Enrico Bertini, Antonio Falace, Marina Pedemonte, Andrea Rossi, Adele D'Amico, Sara Scapolan, Laura Bergamino, Stefania Petrini, Denise Cassandrini, Paolo Broda, Mario Manfredi, Federico Zara, Filippo M Santorelli, Carlo Minetti, Claudio Bruno.   

Abstract

BACKGROUND: Muscle-eye-brain disease is a congenital muscular dystrophy with eye and brain involvement due to POMGnT1 mutations.
OBJECTIVE: To describe the clinical and molecular features of 3 Italian patients with POMGnT1 mutations.
DESIGN: Case reports. PATIENTS: One patient had muscle and brain abnormalities without eye involvement. Two patients had a classic muscle-eye-brain disease phenotype with different levels of clinical severity.
RESULTS: Brain magnetic resonance imaging showed cortical malformation and posterior fossa involvement. Immunofluorescence for glycosylated alpha-dystroglycan performed on muscle biopsy specimens demonstrated an absent signal in 1 patient and reduced staining in 2 patients. Molecular analysis identified 5 mutations, 2 of which are novel.
CONCLUSION: This article adds to what is known about the genotype-phenotype correlation and expands our awareness of the clinical spectrum associated with POMGnT1 mutations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030669     DOI: 10.1001/archneur.63.10.1491

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  10 in total

Review 1.  The o-mannosylation pathway: glycosyltransferases and proteins implicated in congenital muscular dystrophy.

Authors:  Lance Wells
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

Review 2.  Dissecting the molecular basis of the role of the O-mannosylation pathway in disease: α-dystroglycan and forms of muscular dystrophy.

Authors:  David Live; Lance Wells; Geert-Jan Boons
Journal:  Chembiochem       Date:  2013-11-07       Impact factor: 3.164

3.  Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.

Authors:  Naoyuki Kuwabara; Hiroshi Manya; Takeyuki Yamada; Hiroaki Tateno; Motoi Kanagawa; Kazuhiro Kobayashi; Keiko Akasaka-Manya; Yuriko Hirose; Mamoru Mizuno; Mitsunori Ikeguchi; Tatsushi Toda; Jun Hirabayashi; Toshiya Senda; Tamao Endo; Ryuichi Kato
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-04       Impact factor: 11.205

4.  Novel POMGnT1 mutations cause muscle-eye-brain disease in Chinese patients.

Authors:  Hui Jiao; Hiroshi Manya; Shuo Wang; Yanzhi Zhang; Xiaoqing Li; Jiangxi Xiao; Yanling Yang; Kazuhiro Kobayashi; Tatsushi Toda; Tamao Endo; Xiru Wu; Hui Xiong
Journal:  Mol Genet Genomics       Date:  2013-05-21       Impact factor: 3.291

5.  Hedgehog signaling and laminin play unique and synergistic roles in muscle development.

Authors:  Matthew T Peterson; Clarissa A Henry
Journal:  Dev Dyn       Date:  2010-03       Impact factor: 3.780

6.  Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain disease.

Authors:  Ute Hehr; Goekhan Uyanik; Claudia Gross; Maggie C Walter; Axel Bohring; Monika Cohen; Barbara Oehl-Jaschkowitz; Lynne M Bird; Ghiat M Shamdeen; Ulrich Bogdahn; Gerhard Schuierer; Haluk Topaloglu; Ludwig Aigner; Hanns Lochmüller; Jürgen Winkler
Journal:  Neurogenetics       Date:  2007-09-29       Impact factor: 2.660

7.  Novel POMGNT1 point mutations and intragenic rearrangements associated with muscle-eye-brain disease.

Authors:  S Saredi; A Ardissone; A Ruggieri; E Mottarelli; L Farina; R Rinaldi; E Silvestri; C Gandioli; S D'Arrigo; F Salerno; L Morandi; P Grammatico; C Pantaleoni; I Moroni; M Mora
Journal:  J Neurol Sci       Date:  2012-05-02       Impact factor: 3.181

8.  Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease.

Authors:  Josef Voglmeir; Sara Kaloo; Nicolas Laurent; Marco M Meloni; Lisa Bohlmann; Iain B H Wilson; Sabine L Flitsch
Journal:  Biochem J       Date:  2011-06-01       Impact factor: 3.857

Review 9.  Clinical and Molecular Spectrum of Muscular Dystrophies (MDs) with Intellectual Disability (ID): a Comprehensive Overview.

Authors:  Malihe Mohamadian; Mandana Rastegar; Negin Pasamanesh; Ata Ghadiri; Pegah Ghandil; Mohsen Naseri
Journal:  J Mol Neurosci       Date:  2021-11-02       Impact factor: 3.444

10.  Dystroglycan 1: A new candidate gene for patellar luxation in Chihuahua dogs.

Authors:  Pattarawadee Srinarang; Korakot Nganvongpanit; Waranee Pradit; Kittisak Buddhachat; Puntita Siengdee; Kumpanart Soontornvipart; Siriwadee Chomdej
Journal:  Vet World       Date:  2018-09-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.